摘要
新版《中华人民共和国药典》对生物制品的质量要求更高,其中对残留宿主细胞蛋白(HCP)在生物制品中含量的要求也越来越严格。目前HCP研究领域进展迅速。此文对生物制品中宿主残留蛋白的风险分析和检测方法作一综述。
Higher quality for the biological products is required in the latest edition of Pharmacopoeia of the People's Republic of China, and the control on the residual host cell protein (HCP) in biological products is more rigorous. Recently, the progress in the research of residual HCP is very rapid. This paper reviews risk analysis and detection strategy of residual HCP.
出处
《国际生物制品学杂志》
CAS
2012年第2期82-86,共5页
International Journal of Biologicals